May Measurement Month 2019: an analysis of blood pressure screening results from Colombia.

Blood pressure Control Hypertension Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 13 7 2021
Statut: epublish

Résumé

Hypertension awareness and control is poor in low- and middle-income countries. Thus, implementing strategies to increase hypertension detection is needed. Colombia participated as one of the 92 countries involved in the third campaign of the May Measurement Month in 2019. Blood pressure (BP) was measured in 48 324 volunteers from 13 departments in Colombia. In total, 27.9% individuals were identified with hypertension. Of those with hypertension, 63.7% were aware of their condition, 60.0% were on antihypertensive medication, and 38.4% had controlled BP. These results showed low levels of awareness, treatment, and control of hypertension in this sample of subjects volunteered to participate, suggest the urgent necessity of implementing programmes to improve the diagnosis and management of hypertension in Colombia.

Identifiants

pubmed: 34248430
doi: 10.1093/eurheartj/suab039
pii: suab039
pmc: PMC8263072
doi:

Types de publication

Journal Article

Langues

eng

Pagination

B46-B48

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2021.

Références

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D40-D43
pubmed: 31043874
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
Lancet. 2019 Oct 5;394(10205):1231-1242
pubmed: 31488369
J Clin Hypertens (Greenwich). 2020 Dec;22(12):2285-2295
pubmed: 33045133
Lancet Public Health. 2017 Sep;2(9):e411-e419
pubmed: 29253412
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33148540
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
J Hypertens. 2016 Dec;34(12):2344-2352
pubmed: 27662189
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H43-H46
pubmed: 32884467

Auteurs

Patricio Lopez-Jaramillo (P)

Instituto de Investigaciones Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia.

Jose P Lopez-Lopez (JP)

Instituto de Investigaciones Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia.

Johanna Otero (J)

Instituto de Investigaciones Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia.

Natalia Alarcon-Ariza (N)

Instituto de Investigaciones Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia.

Margarita Mogollon-Zehr (M)

Instituto de Investigaciones Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia.

Paul Anthony Camacho (PA)

Dirección de Investigaciones, FOSCAL, Floridablanca, Colombia.

Gregorio Sanchez (G)

Hospital San Juan de Dios Armenia, Universidad del Quindío, Armenia, Colombia.

Claudia Narvaez (C)

Departamento de Epidemiología, Hospital Susana López de Valencia, Popayán, Colombia.

Maria Casanova (M)

Programa de Medicina Interna, Universidad Libre, Cali, Colombia.

Edgar Arcos (E)

Fundación Centro de Obesidad y Metabolismo COMETA, Pasto, Colombia.

Gustavo Aroca (G)

Facultad de Medicina, Universidad Simón Bolívar and Clínica de la Costa, Barranquilla, Colombia.

Adalberto Quintero (A)

Institución CARDIODIAGNOSTICO S.A., Barranquilla, Colombia.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, London, UK.
Department of Primary Care and Public Health, Imperial College London, London, UK.

Giles Partington (G)

Imperial Clinical Trials Unit, Imperial College London, London, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, London, UK.

Classifications MeSH